Disparities in First Dose COVID-19 Vaccination Coverage among Children 5–11 Years of Age, United States
Neil Chandra Murthy
, Elizabeth Zell, Hannah E. Fast, Bhavini Patel Murthy, Lu Meng, Ryan Saelee, Tara Vogt, Kevin Chatham-Stephens, Christina Ottis, Lauren Shaw, Lynn Gibbs-Scharf, LaTreace Harris, and Terence Chorba
Author affiliations: Centers for Disease Control and Prevention, Atlanta, Georgia, USA (N.C. Murthy, H.E. Fast, B.P. Murthy, R. Saelee, T. Vogt, K. Chatham-Stephens, C. Ottis, L. Shaw, L. Gibbs-Scharf, L. Harris, T. Chorba); CDC COVID-19 Response Team, Atlanta (N.C. Murthy, E. Zell, H.E. Fast, B.P. Murthy, L. Meng, R. Saelee, T. Vogt, K. Chatham-Stephens, C. Ottis, L. Shaw, L. Gibbs-Scharf, L. Harris, T. Chorba); US Public Health Service Commissioned Corps, Rockville, Maryland, USA (N.C. Murthy, B.P. Murthy, K. Chatham-Stephens); Stat-Epi Associates, Inc., Ponte Vedra Beach, Florida, USA (E. Zell); General Dynamics Information Technology Inc., Falls Church, Virginia, USA (L. Meng)
Figure 1. Daily and cumulative totals of the number of children 5–11 years of age who received the first dose of the Pfizer-BioNTech COVID-19 vaccine (Pfizer Inc., https://www.pfizer.com) by date of vaccination and age group, United States, November 2–December 31, 2021.
Page created: February 24, 2022
Page updated: April 19, 2022
Page reviewed: April 19, 2022
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.